08045816223
Send Inquiry
Sodium Meglumine Diatrizoate
Product Details:
- Classification Organic Compound, Pharmaceutical Chemical
- CAS No 737-31-5
- EINECS No 200-548-8
- Type API (Active Pharmaceutical Ingredient)
- Usage Pharmaceuticals Used as contrast medium in X-ray imaging
- Color Colorless
- Physical State Liquid
- Click to View more
Sodium Meglumine Diatrizoate Price And Quantity
- 350 INR/Piece
- 10 Piece
- 6.07.7
- Medical Imaging, Radiodiagnostics
- Freely soluble in water
- 29242990
- >98% (Pharmaceutical Grade)
- 24 Months
- Store at 2C to 25C, protected from light
- Meglumine sodium diatrizoate, Urografin
- USP / BP / EP
- Non-flammable, for professional use only
- C11H8I3N2NaO4C7H17NO5
Sodium Meglumine Diatrizoate Product Specifications
- 500 ml, 1 L, or as required
- Meets pharmaceutical grade requirements
- Liquid
- API (Active Pharmaceutical Ingredient)
- Sodium Meglumine Diatrizoate
- Colorless
- Pharmaceuticals Used as contrast medium in X-ray imaging
- Organic Compound, Pharmaceutical Chemical
- Clear solution
- 737-31-5
- 200-548-8
- 6.07.7
- Medical Imaging, Radiodiagnostics
- Freely soluble in water
- 29242990
- >98% (Pharmaceutical Grade)
- 24 Months
- Store at 2C to 25C, protected from light
- Meglumine sodium diatrizoate, Urografin
- USP / BP / EP
- Non-flammable, for professional use only
- C11H8I3N2NaO4C7H17NO5
Sodium Meglumine Diatrizoate Trade Information
- 1000 Piece Per Day
- 7 Days
Product Description
We are engaged in offering premium Sodium Meglumine Diatrizoate that is used for angiography and urography. Offered product in processed under the guidance of skilled professionals, making optimum utilization of high grade tools and technology. This product matches the international quality standards in terms of quality and flawlessness. Offered product is precisely tested for quality through set parameters of industry to avail best outcome to patrons. Moreover, Sodium Meglumine Diatrizoate is available in temper proof packing for safe and convenient transit.
1ml Urografin 60% contains
- Diatrizoic Acid USP. 471.78 mg
- Meglumine USP. 125.46 mg
- (Total Iodine content is 20ml content 5.84 g)
- 1ml Urografin 76% contains
- Diatrizoic acid USP. 597.30 mg
- Meglumine USP. 159.24 mg
(Total Iodine content in 20ml content 7.40g. 50Ml content 18.50g, 100ml content 37g in Aqueous solution)
lntravenous and retrograde urography.
Also for all angiographic examinations as well as for amniography, arthrography, intraoperative cholangiography, fistulography, hysterosalpingography, splenoportography, vesiculography and others.
Urografin is not to be used for myelography, ventricuiography or cisternography, since it is likely to provoke neurotoxic symptoms in these examinations.
Contraindications
Manifest hyperthyrodism, decompensate cardiac insufficiency.
Hysterosalpingography must not be performed during pregnancy or in the presence of acute inflammatory processes in the pelvic cavity.
Please note
The contrast medium solution should not be drawn into the syringe or the infusion bottle until immediately before the examination. Vials containing contrast medium solutions are not intended for the withdrawal of multiple doses. The rubber stopper should never be pierced more than once. the use of cannulas with a long tip and a diameter of maximally 18G is recommended for piercing the stopper and drawing up the contrast medium (dedicated withdrawal cannulas with a side hole e.g. Nocore-Admix cannulas, are particularly suitable).
Contrast medium not used in one examination session must be discarded. The need for examination merits particularly careful consideration in hypersensitivity to iodinated contrast media, severe impairment of hepatic or renal function, cardiac and circulatory insufficiency, pulmonary emphysema, poor general health, cerebral spasmodic conditions, latent hyperthyroidism, bland nodular goitre and multiple myeloma.
Fluid intake should not be restricted before the use of hypertonic contrast media in patients with multiple myeloma, diabetes melliast media in patients with multiple miguria or gout and in babies, young children and patients in a very poor general state of health.
Premedication with alpha-receptor blockers is recommended in phaeochromocytoma patients because of the risk of blood pressure crises. Following the administration of iodinated renal contrast media, the capacity of the thyroid tissue to take up radioisotopes for diagnosing disorders of the thyroid/in reduced for up to 2 weeks, and even longer in individual cases.
The package insert and the scientific brochure should be consulted for side effects, administration during pregnancy and in patients with allergic disposition, special notes as well as suggestions for the treatment of contrast medium incidents, etc.
Superior Contrast for Diagnostic Imaging
Sodium Meglumine Diatrizoate offers exceptional radiopacity, enhancing the diagnostic clarity of medical imaging procedures such as X-rays. Its high purity ensures reliable performance as a contrast agent, supporting precise visualization of internal structures for improved patient outcomes.
Quality Assurance and Compliance
Compliant with USP, BP, and EP standards, this solution meets stringent pharmaceutical grade requirements. Its clear and colorless appearance, consistent solubility, and robust stability profile ensure safe and dependable use in clinical environments, backed by a validated shelf life and trusted manufacturing practices.
FAQ's of Sodium Meglumine Diatrizoate:
Q: How is Sodium Meglumine Diatrizoate used in medical imaging?
A: Sodium Meglumine Diatrizoate is administered as a liquid contrast medium during X-ray and radiodiagnostic procedures. It enhances image contrast by increasing the visibility of organs, blood vessels, and tissues, aiding physicians in accurate diagnosis.Q: What are the recommended storage conditions for Sodium Meglumine Diatrizoate?
A: Store the product at a temperature between 2C and 25C, protected from light exposure. Proper storage ensures optimal stability and maintains its effectiveness throughout its 24-month shelf life.Q: When should Sodium Meglumine Diatrizoate be used?
A: This compound is indicated for use during medical imaging procedures, particularly when enhanced contrast is necessary for clear visualization of internal structures. Usage is restricted to professional healthcare settings.Q: Where is Sodium Meglumine Diatrizoate typically supplied and utilized?
A: It is supplied to hospitals, imaging centers, and pharmaceutical facilities in India and internationally, primarily for use in clinical environments where radiodiagnostic imaging is performed.Q: What process ensures the quality and purity of this compound?
A: Sodium Meglumine Diatrizoate is manufactured under strict adherence to pharmaceutical standards (USP, BP, EP), with rigorous testing for purity (>98%) and compliance with safety and quality requirements.Q: What are the benefits of using Sodium Meglumine Diatrizoate in radiodiagnostics?
A: Its excellent water solubility, stability, and clarity provide enhanced image contrast, improving diagnostic accuracy and efficiency in X-ray and related imaging procedures.Q: Is Sodium Meglumine Diatrizoate safe and suitable for pharmaceutical applications?
A: Yes, it is classified as non-flammable and meets all pharmaceutical grade requirements. Its safety and efficacy make it suitable for professional use as an active pharmaceutical ingredient in contrast imaging.
Price:
- 50
- 100
- 200
- 250
- 500
- 1000+
Other Products in 'Contrast Media' category
GST : 07AAACR0780M1Z7
- 310, Deep Shikha Building, No. 8, Rajendra Place,New Delhi - 110008, India
- Phone :08045816223
|
- Mr Gurpreet Suri (Director)
- Mobile :08045816223
-
info@regeimaging.com
Send Inquiry
Send Inquiry
Send SMS |
REGE IMAGING & CINE FILMS (P) LTD.
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |
